Health
NHS England spends £160m on new ‘Covid-friendly’ cancer drugs – The Guardian
Patients to be given treatments less likely to damage immune system and in some cases able to be taken at home
NHS England is spending £160m on new Covid-friendly cancer drugs that will be less likely to damage the immune system and, in some cases, can be taken at home so that patients do not have to visit hospital.
NHS England said 2,000 patients had already benefitted from a range of treatments approved for use as swaps for existing drugs. More will be available from this week, after a series of deals struck between the NHS and pharma companies, it said in a statement.
Some of these new options mean …
-
Noosa News18 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General16 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
General11 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
Business19 hours agoSolid superannuation gains continue to roll in